Cargando…

Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients

BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Su, Mo, Meilan, Xiao, Shan, Li, Longfei, Hu, Xiuyu, Hong, Ling, Wang, Linlin, Lian, Ruochun, Huang, Chunyu, Zeng, Yong, Diao, Lianghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546360/
https://www.ncbi.nlm.nih.gov/pubmed/33101210
http://dx.doi.org/10.3389/fendo.2020.575337
_version_ 1783592214865117184
author Liu, Su
Mo, Meilan
Xiao, Shan
Li, Longfei
Hu, Xiuyu
Hong, Ling
Wang, Linlin
Lian, Ruochun
Huang, Chunyu
Zeng, Yong
Diao, Lianghui
author_facet Liu, Su
Mo, Meilan
Xiao, Shan
Li, Longfei
Hu, Xiuyu
Hong, Ling
Wang, Linlin
Lian, Ruochun
Huang, Chunyu
Zeng, Yong
Diao, Lianghui
author_sort Liu, Su
collection PubMed
description BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and complications in infertile women undergoing their first in vitro fertilization (IVF) treatment, taking into account important confounders. METHODS: We performed a retrospective cohort study of 7,678 infertile women, including 666 women with PCOS and 7,012 controls undergoing their first IVF treatment at a private fertility center from January 2010 to December 2017. Our main outcome was the impact of PCOS on adverse pregnancy outcomes (miscarriage, preterm delivery, pregnancy-induced hypertension) and pregnancy outcomes (live birth rate, clinical pregnancy rate, implantation rate). PCOS effects were summarized by adjusted odds ratios (aORs) with 95% confidence intervals (CIs) after controlling for maternal characteristics. RESULTS: After adjusting for differences in maternal age, BMI, infertility duration, total dose of gonadotropin, serum E(2) and endometrial thickness on the day of hCG trigger, number of fertilized occytes, number of embryos transferred, embryo type (cleavage-stage embryo or blastocyst) and quality, women with PCOS had an increased risk of developing unfavorable pregnancy complications, including miscarriage (aOR 1.629, 95% CI 1.240–2.141), very preterm delivery (< 32 weeks) (aOR 2.072, 95% CI 1.133–3.791). For pregnancy outcomes, PCOS was associated with higher clinical pregnancy rate (aOR 1.248, 95% CI 1.038–1.501) and implantation rate (aOR 1.238, 95% CI 1.030–1.489) after adjusting for the above-mentioned confounders. CONCLUSIONS: Women with PCOS are at increased risk of adverse pregnancy outcomes after adjusting for differences in maternal characteristics. These women may need more frequent medical consultants and management during pregnancy and parturition.
format Online
Article
Text
id pubmed-7546360
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75463602020-10-22 Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients Liu, Su Mo, Meilan Xiao, Shan Li, Longfei Hu, Xiuyu Hong, Ling Wang, Linlin Lian, Ruochun Huang, Chunyu Zeng, Yong Diao, Lianghui Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: To investigate whether PCOS affects pregnancy outcomes and complications in infertile women undergoing their first in vitro fertilization (IVF) treatment, taking into account important confounders. METHODS: We performed a retrospective cohort study of 7,678 infertile women, including 666 women with PCOS and 7,012 controls undergoing their first IVF treatment at a private fertility center from January 2010 to December 2017. Our main outcome was the impact of PCOS on adverse pregnancy outcomes (miscarriage, preterm delivery, pregnancy-induced hypertension) and pregnancy outcomes (live birth rate, clinical pregnancy rate, implantation rate). PCOS effects were summarized by adjusted odds ratios (aORs) with 95% confidence intervals (CIs) after controlling for maternal characteristics. RESULTS: After adjusting for differences in maternal age, BMI, infertility duration, total dose of gonadotropin, serum E(2) and endometrial thickness on the day of hCG trigger, number of fertilized occytes, number of embryos transferred, embryo type (cleavage-stage embryo or blastocyst) and quality, women with PCOS had an increased risk of developing unfavorable pregnancy complications, including miscarriage (aOR 1.629, 95% CI 1.240–2.141), very preterm delivery (< 32 weeks) (aOR 2.072, 95% CI 1.133–3.791). For pregnancy outcomes, PCOS was associated with higher clinical pregnancy rate (aOR 1.248, 95% CI 1.038–1.501) and implantation rate (aOR 1.238, 95% CI 1.030–1.489) after adjusting for the above-mentioned confounders. CONCLUSIONS: Women with PCOS are at increased risk of adverse pregnancy outcomes after adjusting for differences in maternal characteristics. These women may need more frequent medical consultants and management during pregnancy and parturition. Frontiers Media S.A. 2020-09-25 /pmc/articles/PMC7546360/ /pubmed/33101210 http://dx.doi.org/10.3389/fendo.2020.575337 Text en Copyright © 2020 Liu, Mo, Xiao, Li, Hu, Hong, Wang, Lian, Huang, Zeng and Diao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liu, Su
Mo, Meilan
Xiao, Shan
Li, Longfei
Hu, Xiuyu
Hong, Ling
Wang, Linlin
Lian, Ruochun
Huang, Chunyu
Zeng, Yong
Diao, Lianghui
Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title_full Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title_fullStr Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title_full_unstemmed Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title_short Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients
title_sort pregnancy outcomes of women with polycystic ovary syndrome for the first in vitro fertilization treatment: a retrospective cohort study with 7678 patients
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546360/
https://www.ncbi.nlm.nih.gov/pubmed/33101210
http://dx.doi.org/10.3389/fendo.2020.575337
work_keys_str_mv AT liusu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT momeilan pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT xiaoshan pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT lilongfei pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT huxiuyu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT hongling pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT wanglinlin pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT lianruochun pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT huangchunyu pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT zengyong pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients
AT diaolianghui pregnancyoutcomesofwomenwithpolycysticovarysyndromeforthefirstinvitrofertilizationtreatmentaretrospectivecohortstudywith7678patients